INGESTIBLE THERAPY ACTIVATOR SYSTEM AND METHOD
First Claim
Patent Images
1. A system for providing instructions to a therapeutic device, the system comprising:
- an ingestible unit comprising;
a housing; and
an output module secured within the housing for providing an effector instruction,wherein the ingestible unit provides the effector instruction to the output module upon activation in response to occurrence of a desired event; and
a responder module in communication with the therapeutic device for receiving and processing the effector instruction, wherein the effector instruction alters at least an operation of the therapeutic device.
2 Assignments
0 Petitions
Accused Products
Abstract
An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.
-
Citations
13 Claims
-
1. A system for providing instructions to a therapeutic device, the system comprising:
-
an ingestible unit comprising; a housing; and an output module secured within the housing for providing an effector instruction, wherein the ingestible unit provides the effector instruction to the output module upon activation in response to occurrence of a desired event; and a responder module in communication with the therapeutic device for receiving and processing the effector instruction, wherein the effector instruction alters at least an operation of the therapeutic device. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. (canceled)
-
8. A method for providing instructions to a therapy unit using an ingestible device, the method comprising the steps of:
-
programming an effector module of the ingestible device; ingesting the ingestible device; activating the ingestible device upon reaching a target site, wherein the target site is characterized by the presence of conducting fluid; sending an effector instruction via the effector module; and receiving and processing, via a responder module associated with the therapeutic device, the effector instruction, resulting in a response by the therapeutic device.
-
-
9. A system for controlling therapy delivery, the system comprising:
-
a capsule; an ionic emission unit positioned within the capsule for producing a current flow through ionic emission, wherein the ionic emission module includes a pair of materials that produce a voltage potential when exposed to a conducting fluid; a conductance control module positioned between the pair of materials and electrically coupled thereto for controlling conductance to produce a unique current signature that carries an effector instruction. - View Dependent Claims (10, 11, 12)
-
-
13-20. -20. (canceled)
Specification